Robotic drug-delivery pill company Rani Therapeutics Holdings (NSDQ:RANI) has added Lisa Rometty to its board of directors.
Rometty is the president of CVS Kidney Care. Previously, she worked as an executive at Syneos Health and IBM Watson Health.
“I’m delighted to welcome Lisa to our Board,” said Talat Imran, CEO of Rani Therapeutics, in a statement. “Lisa’s expertise in commercializing new products and forming strategic partnerships will play a critical role in the ongoing development of the RaniPill technology and its anticipated future commercialization.”
“I’m thrilled to join this world-class team as we lay the groundwork for the future commercialization of their novel RaniPill technology and transform how people are treated with life-saving biologic therapies,” Rometty said in a LinkedIn update.
Filed Under: Gastroenterology, Immunology